GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Short-Term Debt

Voluntis (XPAR:ALVTX) Short-Term Debt : €4.22 Mil (As of Jun. 2021)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Short-Term Debt?

Voluntis's Short-Term Debt for the quarter that ended in Jun. 2021 was €4.22 Mil.

Voluntis's quarterly Short-Term Debt declined from Jun. 2020 (€2.62 Mil) to Dec. 2020 (€1.92 Mil) but then increased from Dec. 2020 (€1.92 Mil) to Jun. 2021 (€4.22 Mil).

Voluntis's annual Short-Term Debt increased from Dec. 2018 (€1.44 Mil) to Dec. 2019 (€2.77 Mil) but then declined from Dec. 2019 (€2.77 Mil) to Dec. 2020 (€1.92 Mil).


Voluntis Short-Term Debt Historical Data

The historical data trend for Voluntis's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Short-Term Debt Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Short-Term Debt
- - 1.44 2.77 1.92

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.94 2.77 2.62 1.92 4.22

Voluntis Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Voluntis Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Voluntis's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines